Retatrutide (LY3437943) is a novel triple agonist targeting GLP-1, GIP, and glucagon receptors, currently under investigation for metabolic disorders. This research compound shows potential in preclinical studies for various therapeutic applications.
Our Retatrutide is supplied as white lyophilized powder with guaranteed purity for research applications. The compound demonstrates solubility in water (5mg/ml) and requires storage at -20°C to maintain stability.
Potential research applications include metabolic studies, weight management research, and diabetes-related investigations. As with all research compounds, this product is intended for laboratory use only by qualified professionals.
Each batch is accompanied by comprehensive analytical documentation including HPLC purity reports and mass spectrometry verification to ensure research quality standards.